marrick wealth, LLC

CIK 0002109850 · IRVINE, CA · Quarter end: 2026-06-30 · Filed on: 2026-07-14 · Open the SEC source

marrick wealth, LLC reported 62 positions worth $140.8M as of June 30, 2026 (13F filed July 14, 2026). Largest holding: DFAC (24.8%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$140.8M
2026 Q2
Positions
62
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
75.2%
Est. Net Flow (Q)
2026 Q2
10 / 62 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1DFACDIMENSIONAL ETF TRUSTSH$34.9M24.75%785,884
2DFAXDIMENSIONAL ETF TRUSTSH$24.5M17.39%664,948
3AVUSAMERICAN CENTY ETF TRSH$15.1M10.70%117,661
4DFCFDIMENSIONAL ETF TRUSTSH$8.0M5.68%189,699
5AVDEAMERICAN CENTY ETF TRSH$7.7M5.49%86,643
6DFGPDIMENSIONAL ETF TRUSTSH$4.9M3.50%90,617
7DFICDIMENSIONAL ETF TRUSTSH$2.9M2.08%78,550
8AVIGAMERICAN CENTY ETF TRSH$2.7M1.89%64,421
9AVEMAMERICAN CENTY ETF TRSH$2.7M1.89%27,612
10AVREAMERICAN CENTY ETF TRSH$2.5M1.80%53,531

The free plan shows the top 10 positions. The remaining 52 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does marrick wealth, LLC hold as of Q2 2026?

marrick wealth, LLC reported 62 positions worth $140.8M in its Q2 2026 13F filing. Largest positions: DFAC (24.8%), DFAX (17.4%), AVUS (10.7%), DFCF (5.7%) and AVDE (5.5%).

What did marrick wealth, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did marrick wealth, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.